Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Recombinant Erythropoietin Market

Published Date : Nov 2023

The global recombinant erythropoietin market size was valued at US$ 7.01 billion in 2023 and is expected to reach US$ 8.68 billion by 2030, grow at a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030. Re... View more

Coherent Market Insights Dasatinib Drugs Market

Published Date : Nov 2023

The global dasatinib drugs market size is projected to reach US$ 2,198.7 Mn by 2030, from US$ 1,465.0 million in 2023, growing at a CAGR of 6% during the forecast period 2023-2030. Dasatinib is a seco... View more

Coherent Market Insights Glucose Excipient Market

Published Date : Nov 2023

The global glucose excipient market size was valued at US$ 1,058.2 million in 2023 and is projected to reach US$ 1,328.1 million by 2030, growing at a CAGR of 3.3% from 2023 t... View more

Coherent Market Insights Nifedipine Medication Market

Published Date : Nov 2023

Global nifedipine medication market size is estimated to be valued at US$ 1,049.6 Mn in 2023 and is expected to reach US$ 1,967.2 Mn by 2030, by exhibiting a compounded annual growth rate (CAG... View more

Coherent Market Insights Controlled Substance Market

Published Date : Nov 2023

Global Controlled Substance Market size is expected to reach US$ 58.4 Bn by 2030, from US$ 41.8 Bn in 2023, by exhibiting a compounded annual growth rate (CAGR) of 4.9% during the forecast per... View more

Coherent Market Insights Atezolizumab Market

Published Date : Nov 2023

The Global Atezolizumab Market size is estimated to be valued at US$ 2.68 billion in 2023 and is expected to reach US$ 7.86 billion by 2030, grow at a compound annual growth rate (CAGR) of 16.6% from 2023 to 2030. Ate... View more

Coherent Market Insights Orodispersible Tablets Market

Published Date : Nov 2023

Global orodispersible tablets market experienced a significant expansion in recent years, and is expected to witness growth during the forecast period from 2023 to 2030. Orodispersible tablets, a... View more

Coherent Market Insights Aortic Stenosis Market

Published Date : Nov 2023

The Global Aortic Stenosis Market size is expected to reach US$ 16.77 billion by 2030, from US$ 8.33 billion in 2023, at a CAGR of 10.5% during the forecast period. The global aortic stenosis market is expected to ... View more

Coherent Market Insights Medical Probiotics Market

Published Date : Nov 2023

The medical probiotics market size is expected to reach US$ 62.25 Bn by 2030, from US$ 40.50 Bn in 2023, at a CAGR of 6.3% during the forecast period. The growth of the medical probiotics Market is driven by factors such as rising health consciousness... View more

Coherent Market Insights Smallpox Treatment Market

Published Date : Nov 2023

The global smallpox treatment market size was valued at US$ 67.5 million in 2023 and is expected to reach US$ 78 million by 2030, grow at a compound annual growth rate (CAGR) of 2.1% from 2023 to 2030... View more

Coherent Market Insights Bacterial Vaccines Market

Published Date : Nov 2023

Global bacterial vaccines market size is estimated to be valued at US$ 23.77 Bn in 2023 and is expected to reach US$ 40.74 Bn by 2030, by exhibiting a compound annual growth rate (CAGR) of 8% from 2023 to 2030. The ma... View more

Coherent Market Insights Asia Japan South Korea China India Asean Alcohol Dependency Treatment Market

Published Date : Nov 2023

The Asia (Japan, South Korea, China, India, ASEAN) alcohol dependency treatment market size was valued at US$ 867.5 million and is expected to reach US$ 1,242.4 million by 2030, growing at a CAGR of 5.3% from 2023 to 2030... View more

Coherent Market Insights Phenobarbital Market

Published Date : Nov 2023

Global Phenobarbital Market size is estimated to be valued at US$ 1.58 billion in 2023 and is expected to reach US$ 2.23 billion by 2030, by exhibiting a compound annual growth rate (CAGR) of 5% from 2023 to 2030.... View more

Coherent Market Insights Immune Cell Engineering Market

Published Date : Nov 2023

The global immune cell engineering market size is expected to reach US$ 11.66 Bn by 2030, from US$ 2.82 Bn in 2023, at a CAGR of 22.5% during the forecast period. Immune cell engineering involves modifying immune c... View more

Coherent Market Insights Altapharma Market

Published Date : Nov 2023

Global Altapharma Market is expected to reach US$ 398.6 Mn by 2030, from US$ 200.8 Mn in 2023, exhibiting a CAGR of 10.3% during the forecast period. Altapharma includes pharmaceutical drugs and medicines that are ... View more

Coherent Market Insights Mosquito Borne Disease Market

Published Date : Nov 2023

Global mosquito borne disease market size is expected to reach US$ 5.10 Bn by 2030, from US$ 3.11 Bn in 2023, exhibiting a CAGR of 7.3% during the forecast period. Mosquito borne diseases are illnesses caused by pa... View more

Coherent Market Insights Macrophage Marker Market

Published Date : Nov 2023

The Global Macrophage Marker Market was valued at US$ 256.2 million in 2023 and is projected to reach US$ 398.2 million by 2030, at a CAGR of 6.5% from 2023 to 2030. The increasing pr... View more

Coherent Market Insights Rosacea Treatment Market

Published Date : Nov 2023

The Global Rosacea Treatment Market size is expected to reach US$ 2.96 billion by 2030, from US$ 1.91 billion in 2023, at a CAGR of 6.5% during the forecast period. The Global Rosacea Treatment Market is segme... View more

Coherent Market Insights Estrogen Blockers Market

Published Date : Nov 2023

The global estrogen blockers market size was valued at US$ 15.02 billion in 2023 and is expected to reach US$ 23.34 billion by 2030, growing at a CAGR of 6.5% from 2023 to 2030. ... View more

Coherent Market Insights Anti Radiation Drugs Market

Published Date : Nov 2023

Global Anti-Radiation Drugs Market size is expected to be valued at US$ 587.4 Mn in 2023, and is expected to reach US$ 931 Mn by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2023 to 2030. ... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.